Secretive biotechnology company Receptor Life Sciences has raised a funding round totaling just over $7.5 million, according to a filing with… Read More
Nine years after he underwent treatment for non-Hodgkin’s lymphoma, a potentially fatal but treatable form of cancer, Microsoft co-founder Paul… Read More
Seattle-based biotech company Adaptive Biotechnologies announced Friday that the FDA has cleared its clonoSEQ platform for use. It marks first time a technology… Read More
Today’s featured stories Nest’s digital health ambitions revealed in records from secretive purchase of Seattle startup Senosis Backed by Seattle… Read More
Silverback Therapeutics, a stealthy biotechnology startup, gave the first glimpse of its technology Wednesday as it announced an additional $37.5… Read More
High-altitude activities are no walk in the park. From hardcore mountaineering to downhill skiing, most high-altitude adventurers have nerves of steel… Read More